 | • レポートコード：GIR-2104Z07724 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、In situハイブリダイゼーションのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。In situハイブリダイゼーションの種類別市場規模（放射性同位元素、非放射性ラベル）、用途別市場規模（がん診断、免疫、神経科、細胞、感染症）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・In situハイブリダイゼーションの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Laboratories、F. Hoffmann-La Roche、Leica Biosystems Nussloch、Agilent Technologies、Thermo Fisher Scientific、Merck、PerkinElmer、Exiqon A/S、BioGenex Laboratories、Advanced Cell Diagnostics、Bio SB ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：放射性同位元素、非放射性ラベル ・用途別分析2016年-2026年：がん診断、免疫、神経科、細胞、感染症 ・In situハイブリダイゼーションの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・In situハイブリダイゼーションのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・In situハイブリダイゼーションのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・In situハイブリダイゼーションの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・In situハイブリダイゼーションの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The In-Situ Hybridization market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global In-Situ Hybridization size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global In-Situ Hybridization market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
In-Situ Hybridization market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Radioactive isotopes
Non-radioactive labels
Market segment by Application, can be divided into
Cancer Diagnosis
Immunology
Neuroscience
Cytology
Infectious Diseases
Market segment by players, this report covers
Abbott Laboratories
F. Hoffmann-La Roche
Leica Biosystems Nussloch
Agilent Technologies
Thermo Fisher Scientific
Merck
PerkinElmer
Exiqon A/S
BioGenex Laboratories
Advanced Cell Diagnostics
Bio SB
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of In-Situ Hybridization
1.2 Classification of In-Situ Hybridization by Type
1.2.1 Overview: Global In-Situ Hybridization Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global In-Situ Hybridization Revenue Market Share by Type in 2020
1.2.3 Radioactive isotopes
1.2.4 Non-radioactive labels
1.3 Global In-Situ Hybridization Market by Application
1.3.1 Overview: Global In-Situ Hybridization Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Cancer Diagnosis
1.3.3 Immunology
1.3.4 Neuroscience
1.3.5 Cytology
1.3.6 Infectious Diseases
1.4 Global In-Situ Hybridization Market Size & Forecast
1.5 Global In-Situ Hybridization Market Size and Forecast by Region
1.5.1 Global In-Situ Hybridization Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global In-Situ Hybridization Market Size by Region, (2016-2021)
1.5.3 North America In-Situ Hybridization Market Size and Prospect (2016-2026)
1.5.4 Europe In-Situ Hybridization Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific In-Situ Hybridization Market Size and Prospect (2016-2026)
1.5.6 South America In-Situ Hybridization Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa In-Situ Hybridization Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 In-Situ Hybridization Market Drivers
1.6.2 In-Situ Hybridization Market Restraints
1.6.3 In-Situ Hybridization Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories In-Situ Hybridization Product and Solutions
2.1.4 Abbott Laboratories In-Situ Hybridization Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 F. Hoffmann-La Roche
2.2.1 F. Hoffmann-La Roche Details
2.2.2 F. Hoffmann-La Roche Major Business
2.2.3 F. Hoffmann-La Roche In-Situ Hybridization Product and Solutions
2.2.4 F. Hoffmann-La Roche In-Situ Hybridization Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.3 Leica Biosystems Nussloch
2.3.1 Leica Biosystems Nussloch Details
2.3.2 Leica Biosystems Nussloch Major Business
2.3.3 Leica Biosystems Nussloch In-Situ Hybridization Product and Solutions
2.3.4 Leica Biosystems Nussloch In-Situ Hybridization Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Leica Biosystems Nussloch Recent Developments and Future Plans
2.4 Agilent Technologies
2.4.1 Agilent Technologies Details
2.4.2 Agilent Technologies Major Business
2.4.3 Agilent Technologies In-Situ Hybridization Product and Solutions
2.4.4 Agilent Technologies In-Situ Hybridization Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Agilent Technologies Recent Developments and Future Plans
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific In-Situ Hybridization Product and Solutions
2.5.4 Thermo Fisher Scientific In-Situ Hybridization Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck In-Situ Hybridization Product and Solutions
2.6.4 Merck In-Situ Hybridization Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Merck Recent Developments and Future Plans
2.7 PerkinElmer
2.7.1 PerkinElmer Details
2.7.2 PerkinElmer Major Business
2.7.3 PerkinElmer In-Situ Hybridization Product and Solutions
2.7.4 PerkinElmer In-Situ Hybridization Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 PerkinElmer Recent Developments and Future Plans
2.8 Exiqon A/S
2.8.1 Exiqon A/S Details
2.8.2 Exiqon A/S Major Business
2.8.3 Exiqon A/S In-Situ Hybridization Product and Solutions
2.8.4 Exiqon A/S In-Situ Hybridization Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Exiqon A/S Recent Developments and Future Plans
2.9 BioGenex Laboratories
2.9.1 BioGenex Laboratories Details
2.9.2 BioGenex Laboratories Major Business
2.9.3 BioGenex Laboratories In-Situ Hybridization Product and Solutions
2.9.4 BioGenex Laboratories In-Situ Hybridization Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 BioGenex Laboratories Recent Developments and Future Plans
2.10 Advanced Cell Diagnostics
2.10.1 Advanced Cell Diagnostics Details
2.10.2 Advanced Cell Diagnostics Major Business
2.10.3 Advanced Cell Diagnostics In-Situ Hybridization Product and Solutions
2.10.4 Advanced Cell Diagnostics In-Situ Hybridization Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Advanced Cell Diagnostics Recent Developments and Future Plans
2.11 Bio SB
2.11.1 Bio SB Details
2.11.2 Bio SB Major Business
2.11.3 Bio SB In-Situ Hybridization Product and Solutions
2.11.4 Bio SB In-Situ Hybridization Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Bio SB Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global In-Situ Hybridization Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 In-Situ Hybridization Players Market Share
3.2.2 Top 10 In-Situ Hybridization Players Market Share
3.2.3 Market Competition Trend
3.3 In-Situ Hybridization Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global In-Situ Hybridization Revenue and Market Share by Type (2016-2021)
4.2 Global In-Situ Hybridization Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global In-Situ Hybridization Revenue Market Share by Application (2016-2021)
5.2 In-Situ Hybridization Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America In-Situ Hybridization Revenue by Type (2016-2026)
6.2 North America In-Situ Hybridization Revenue by Application (2016-2026)
6.3 North America In-Situ Hybridization Market Size by Country
6.3.1 North America In-Situ Hybridization Revenue by Country (2016-2026)
6.3.2 United States In-Situ Hybridization Market Size and Forecast (2016-2026)
6.3.3 Canada In-Situ Hybridization Market Size and Forecast (2016-2026)
6.3.4 Mexico In-Situ Hybridization Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe In-Situ Hybridization Revenue by Type (2016-2026)
7.2 Europe In-Situ Hybridization Revenue by Application (2016-2026)
7.3 Europe In-Situ Hybridization Market Size by Country
7.3.1 Europe In-Situ Hybridization Revenue by Country (2016-2026)
7.3.2 Germany In-Situ Hybridization Market Size and Forecast (2016-2026)
7.3.3 France In-Situ Hybridization Market Size and Forecast (2016-2026)
7.3.4 United Kingdom In-Situ Hybridization Market Size and Forecast (2016-2026)
7.3.5 Russia In-Situ Hybridization Market Size and Forecast (2016-2026)
7.3.6 Italy In-Situ Hybridization Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific In-Situ Hybridization Revenue by Type (2016-2026)
8.2 Asia-Pacific In-Situ Hybridization Revenue by Application (2016-2026)
8.3 Asia-Pacific In-Situ Hybridization Market Size by Region
8.3.1 Asia-Pacific In-Situ Hybridization Revenue by Region (2016-2026)
8.3.2 China In-Situ Hybridization Market Size and Forecast (2016-2026)
8.3.3 Japan In-Situ Hybridization Market Size and Forecast (2016-2026)
8.3.4 South Korea In-Situ Hybridization Market Size and Forecast (2016-2026)
8.3.5 India In-Situ Hybridization Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia In-Situ Hybridization Market Size and Forecast (2016-2026)
8.3.7 Australia In-Situ Hybridization Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America In-Situ Hybridization Revenue by Type (2016-2026)
9.2 South America In-Situ Hybridization Revenue by Application (2016-2026)
9.3 South America In-Situ Hybridization Market Size by Country
9.3.1 South America In-Situ Hybridization Revenue by Country (2016-2026)
9.3.2 Brazil In-Situ Hybridization Market Size and Forecast (2016-2026)
9.3.3 Argentina In-Situ Hybridization Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa In-Situ Hybridization Revenue by Type (2016-2026)
10.2 Middle East & Africa In-Situ Hybridization Revenue by Application (2016-2026)
10.3 Middle East & Africa In-Situ Hybridization Market Size by Country
10.3.1 Middle East & Africa In-Situ Hybridization Revenue by Country (2016-2026)
10.3.2 Turkey In-Situ Hybridization Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia In-Situ Hybridization Market Size and Forecast (2016-2026)
10.3.4 UAE In-Situ Hybridization Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global In-Situ Hybridization Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global In-Situ Hybridization Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market In-Situ Hybridization Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global In-Situ Hybridization Revenue (USD Million) by Region (2016-2021)
Table 5. Global In-Situ Hybridization Revenue Market Share by Region (2021-2026)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories In-Situ Hybridization Product and Solutions
Table 9. Abbott Laboratories In-Situ Hybridization Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 11. F. Hoffmann-La Roche Major Business
Table 12. F. Hoffmann-La Roche In-Situ Hybridization Product and Solutions
Table 13. F. Hoffmann-La Roche In-Situ Hybridization Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Leica Biosystems Nussloch Corporate Information, Head Office, and Major Competitors
Table 15. Leica Biosystems Nussloch Major Business
Table 16. Leica Biosystems Nussloch In-Situ Hybridization Product and Solutions
Table 17. Leica Biosystems Nussloch In-Situ Hybridization Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 19. Agilent Technologies Major Business
Table 20. Agilent Technologies In-Situ Hybridization Product and Solutions
Table 21. Agilent Technologies In-Situ Hybridization Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 23. Thermo Fisher Scientific Major Business
Table 24. Thermo Fisher Scientific In-Situ Hybridization Product and Solutions
Table 25. Thermo Fisher Scientific In-Situ Hybridization Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Merck Corporate Information, Head Office, and Major Competitors
Table 27. Merck Major Business
Table 28. Merck In-Situ Hybridization Product and Solutions
Table 29. Merck In-Situ Hybridization Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. PerkinElmer Corporate Information, Head Office, and Major Competitors
Table 31. PerkinElmer Major Business
Table 32. PerkinElmer In-Situ Hybridization Product and Solutions
Table 33. PerkinElmer In-Situ Hybridization Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Exiqon A/S Corporate Information, Head Office, and Major Competitors
Table 35. Exiqon A/S Major Business
Table 36. Exiqon A/S In-Situ Hybridization Product and Solutions
Table 37. Exiqon A/S In-Situ Hybridization Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. BioGenex Laboratories Corporate Information, Head Office, and Major Competitors
Table 39. BioGenex Laboratories Major Business
Table 40. BioGenex Laboratories In-Situ Hybridization Product and Solutions
Table 41. BioGenex Laboratories In-Situ Hybridization Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Advanced Cell Diagnostics Corporate Information, Head Office, and Major Competitors
Table 43. Advanced Cell Diagnostics Major Business
Table 44. Advanced Cell Diagnostics In-Situ Hybridization Product and Solutions
Table 45. Advanced Cell Diagnostics In-Situ Hybridization Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Bio SB Corporate Information, Head Office, and Major Competitors
Table 47. Bio SB Major Business
Table 48. Bio SB In-Situ Hybridization Product and Solutions
Table 49. Bio SB In-Situ Hybridization Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global In-Situ Hybridization Revenue (USD Million) by Players (2019-2021)
Table 51. Global In-Situ Hybridization Revenue Share by Players (2019-2021)
Table 52. Breakdown of In-Situ Hybridization by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. In-Situ Hybridization Players Head Office, Products and Services Provided
Table 54. In-Situ Hybridization Mergers & Acquisitions in the Past Five Years
Table 55. In-Situ Hybridization New Entrants and Expansion Plans
Table 56. Global In-Situ Hybridization Revenue (USD Million) by Type (2016-2021)
Table 57. Global In-Situ Hybridization Revenue Share by Type (2016-2021)
Table 58. Global In-Situ Hybridization Revenue Forecast by Type (2021-2026)
Table 59. Global In-Situ Hybridization Revenue by Application (2016-2021)
Table 60. Global In-Situ Hybridization Revenue Forecast by Application (2021-2026)
Table 61. North America In-Situ Hybridization Revenue by Type (2016-2021) & (USD Million)
Table 62. North America In-Situ Hybridization Revenue by Type (2021-2026) & (USD Million)
Table 63. North America In-Situ Hybridization Revenue by Application (2016-2021) & (USD Million)
Table 64. North America In-Situ Hybridization Revenue by Application (2021-2026) & (USD Million)
Table 65. North America In-Situ Hybridization Revenue by Country (2016-2021) & (USD Million)
Table 66. North America In-Situ Hybridization Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe In-Situ Hybridization Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe In-Situ Hybridization Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe In-Situ Hybridization Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe In-Situ Hybridization Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe In-Situ Hybridization Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe In-Situ Hybridization Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific In-Situ Hybridization Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific In-Situ Hybridization Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific In-Situ Hybridization Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific In-Situ Hybridization Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific In-Situ Hybridization Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific In-Situ Hybridization Revenue by Region (2021-2026) & (USD Million)
Table 79. South America In-Situ Hybridization Revenue by Type (2016-2021) & (USD Million)
Table 80. South America In-Situ Hybridization Revenue by Type (2021-2026) & (USD Million)
Table 81. South America In-Situ Hybridization Revenue by Application (2016-2021) & (USD Million)
Table 82. South America In-Situ Hybridization Revenue by Application (2021-2026) & (USD Million)
Table 83. South America In-Situ Hybridization Revenue by Country (2016-2021) & (USD Million)
Table 84. South America In-Situ Hybridization Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa In-Situ Hybridization Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa In-Situ Hybridization Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa In-Situ Hybridization Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa In-Situ Hybridization Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa In-Situ Hybridization Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa In-Situ Hybridization Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. In-Situ Hybridization Picture
Figure 2. Global In-Situ Hybridization Revenue Market Share by Type in 2020
Figure 3. Radioactive isotopes
Figure 4. Non-radioactive labels
Figure 5. In-Situ Hybridization Revenue Market Share by Application in 2020
Figure 6. Cancer Diagnosis Picture
Figure 7. Immunology Picture
Figure 8. Neuroscience Picture
Figure 9. Cytology Picture
Figure 10. Infectious Diseases Picture
Figure 11. Global In-Situ Hybridization Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global In-Situ Hybridization Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global In-Situ Hybridization Revenue Market Share by Region (2016-2026)
Figure 14. Global In-Situ Hybridization Revenue Market Share by Region in 2020
Figure 15. North America In-Situ Hybridization Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe In-Situ Hybridization Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific In-Situ Hybridization Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America In-Situ Hybridization Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. In-Situ Hybridization Market Drivers
Figure 20. In-Situ Hybridization Market Restraints
Figure 21. In-Situ Hybridization Market Trends
Figure 22. Abbott Laboratories Recent Developments and Future Plans
Figure 23. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 24. Leica Biosystems Nussloch Recent Developments and Future Plans
Figure 25. Agilent Technologies Recent Developments and Future Plans
Figure 26. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 27. Merck Recent Developments and Future Plans
Figure 28. PerkinElmer Recent Developments and Future Plans
Figure 29. Exiqon A/S Recent Developments and Future Plans
Figure 30. BioGenex Laboratories Recent Developments and Future Plans
Figure 31. Advanced Cell Diagnostics Recent Developments and Future Plans
Figure 32. Bio SB Recent Developments and Future Plans
Figure 34. Global In-Situ Hybridization Revenue Share by Players in 2020
Figure 35. In-Situ Hybridization Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players In-Situ Hybridization Revenue Market Share in 2020
Figure 37. Global Top 10 Players In-Situ Hybridization Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global In-Situ Hybridization Revenue Share by Type in 2020
Figure 40. Global In-Situ Hybridization Market Share Forecast by Type (2021-2026)
Figure 41. Global In-Situ Hybridization Revenue Share by Application in 2020
Figure 42. Global In-Situ Hybridization Market Share Forecast by Application (2021-2026)
Figure 43. North America In-Situ Hybridization Sales Market Share by Type (2016-2026)
Figure 44. North America In-Situ Hybridization Sales Market Share by Application (2016-2026)
Figure 45. North America In-Situ Hybridization Revenue Market Share by Country (2016-2026)
Figure 46. United States In-Situ Hybridization Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada In-Situ Hybridization Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico In-Situ Hybridization Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe In-Situ Hybridization Sales Market Share by Type (2016-2026)
Figure 50. Europe In-Situ Hybridization Sales Market Share by Application (2016-2026)
Figure 51. Europe In-Situ Hybridization Revenue Market Share by Country (2016-2026)
Figure 52. Germany In-Situ Hybridization Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France In-Situ Hybridization Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom In-Situ Hybridization Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia In-Situ Hybridization Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy In-Situ Hybridization Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific In-Situ Hybridization Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific In-Situ Hybridization Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific In-Situ Hybridization Revenue Market Share by Region (2016-2026)
Figure 60. China In-Situ Hybridization Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan In-Situ Hybridization Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea In-Situ Hybridization Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India In-Situ Hybridization Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia In-Situ Hybridization Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia In-Situ Hybridization Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America In-Situ Hybridization Sales Market Share by Type (2016-2026)
Figure 67. South America In-Situ Hybridization Sales Market Share by Application (2016-2026)
Figure 68. South America In-Situ Hybridization Revenue Market Share by Country (2016-2026)
Figure 69. Brazil In-Situ Hybridization Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina In-Situ Hybridization Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa In-Situ Hybridization Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa In-Situ Hybridization Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa In-Situ Hybridization Revenue Market Share by Country (2016-2026)
Figure 74. Turkey In-Situ Hybridization Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia In-Situ Hybridization Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE In-Situ Hybridization Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のIn-Situハイブリダイゼーション市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global In-Situ Hybridization Market The global In-Situ Hybridization market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…- 世界の蛍光in situハイブリダイゼーションプローブ市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Fluorescent in Situ Hybridization Probe Market The global Fluorescent in Situ Hybridization Probe market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…
- 世界のIn-situハイブリダイゼーション（ISH）市場規模・現状・予測（2021年-2027年） In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds, Drosophila em…
- 世界のIn Situハイブリダイゼーション市場規模・現状・予測（2021年-2027年） In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough, in the entire tissue, in cells, and in circula…
- 世界のRNAインサイツハイブリダイゼーション市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global RNA In Situ Hybridization Market The global RNA In Situ Hybridization market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…